OS Therapies Inc
OSTX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001795091
No open-market purchases or sales by OS Therapies Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $5.50M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding OS Therapies Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 0 | 7 | +7 |
| Shares | 0 | 160.0K | +160.0K |
| Value | $0 | $447.8K | +$447.8K |
New holders (7)
Institutions that held OS Therapies Inc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 60,435 | $169.2K | 0.00% |
| CM Management, LLC | 50,000 | $140.0K | 0.11% |
| Delta Investment Management, LLC | 18,081 | $50.6K | 0.01% |
| HRT Financial LP | 17,576 | $49.0K | 0.00% |
| Virtu Financial LLC | 10,045 | $28.0K | 0.00% |
| UBS Group AG | 3,806 | $10.7K | 0.00% |
| Armstrong Advisory Group, Inc | 100 | $280 | 0.00% |
Sold out (0)
Institutions that held OS Therapies Inc at the end of Q2 2024 and filed for Q3 2024 without it.
None.